Mobile

Inhaled preprandial human insulin with the AERx® iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and asthma: a 52-week, open-label, multinational, randomised, parallel trial...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004622-81

Inhaled preprandial human insulin with the AERx® iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and asthma: a 52-week, open-label, multinational, randomised, parallel trial to investigate long-term safety

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this trial is to evaluate long-term pulmonary safety profiles comparing preprandial inhaled human insulin with preprandial subcutaneous (sc) injections of insulin aspart, both in combination with basal insulin and/or oral antidiabetic drugs (OADs), in subjects with diabetes and asthma.

Critère d'inclusion

  • Type 1 diabetes Type 2 diabetes Asthma

Liens